FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shan Lu

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Physiology

Cellular Immunity

Disorders

HIV Infections

Co-author Network

Publications

TOP 3
Ke Jin; Shan Lu; Shixia Wang; Yanling Xiao; Chunhua Zhang; Zuhu Huang
Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B.
Olivia O'Connell; Paul Peters; Briana Quitadamo; Jacqueline D Reeves; Alexander Repik; Aaron Wallace; Shixia Wang; Susan Zolla-Pazner; Davide Corti; Maria Duenas-Decamp; Maria Paz Gonzalez-Perez; Xiang-Peng Kong; Rongheng Lin; Shan Lu; Elizabeth D Anton; Paul R Clapham
Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism.
Shixia Wang; Yan Wang; Frank Brewster; Glenda E Gray; Michael Kishko; Katherine Luzuriaga; Mohan Somasundaran; John L Sullivan; Avye Violari; Shengqin Wan; Shan Lu
Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shan Lu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ke Jin; Shan Lu; Shixia Wang; Yanling Xiao; Chunhua Zhang; Zuhu Huang
Protective antibody responses against Clostridium difficile elicited by a DNA vaccine expressing the enzymatic domain of toxin B.
Human vaccines & immunotherapeutics 2013;9(1):63-73.
2013: Olivia O'Connell; Paul Peters; Briana Quitadamo; Jacqueline D Reeves; Alexander Repik; Aaron Wallace; Shixia Wang; Susan Zolla-Pazner; Davide Corti; Maria Duenas-Decamp; Maria Paz Gonzalez-Perez; Xiang-Peng Kong; Rongheng Lin; Shan Lu; Elizabeth D Anton; Paul R Clapham
Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism.
Journal of virology 2013;87(1):187-98.
2012: Shixia Wang; Yan Wang; Frank Brewster; Glenda E Gray; Michael Kishko; Katherine Luzuriaga; Mohan Somasundaran; John L Sullivan; Avye Violari; Shengqin Wan; Shan Lu
Pilot study on the immunogenicity of paired Env immunogens from mother-to-child transmitted HIV-1 isolates.
Human vaccines & immunotherapeutics 2012;8(11):1638-47.
2012: Mingshun Zhang; Kunxue Hong; Zuhu Huang; Yiming Shao; Shixia Wang; Chunhua Zhang; Lu Zhang; Shan Lu
DNA prime-protein boost using subtype consensus Env was effective in eliciting neutralizing antibody responses against subtype BC HIV-1 viruses circulating in China.
Human vaccines & immunotherapeutics 2012;8(11):1630-7.
2012: E Xiaofei; Michelle Debatis; Shan Lu; Bradford M Stadler; Shixia Wang; Timothy F Kowalik
RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.
Journal of virology 2012;86(10):5660-73.
2012: Juan Xu; Wenhong Zhang; Shixia Wang; Weihua Gan; Zuhu Huang; Liwen Ju; Shan Lu
Expression and immunogenicity of novel subunit enterovirus 71 VP1 antigens.
Biochemical and biophysical research communications 2012;420(4):755-61.
2012: Shiyang Pan; Hongbing Shen; Yongqian Shu; Fang Wang; Wenying Xia; Jian Xu; Ting Xu; Chun Zhao; Dan Chen; Qingqing Ding; Yan Geng; Zhibin Hu; Peijun Huang; Puwen Huang; Yachun Lu; Shan Lu
Can plasma DNA monitoring be employed in personalized chemotherapy for patients with advanced lung cancer?
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2012;66(2):131-7.
2012: Guohong Ge; Yaping Han; Shan Lu; Shixia Wang; Chunhua Zhang; Zuhu Huang
Removing N-terminal sequences in pre-S1 domain enhanced antibody and B-cell responses by an HBV large surface antigen DNA vaccine.
PloS one 2012;7(7):e41573.
2011: Shan Lu
Two is better than one.
The Lancet infectious diseases 2011;11(12):889-91.
2011: Shixia Wang; Jon Goguen; Fusheng Li; Shan Lu
Involvement of CD8+ T cell-mediated immune responses in LcrV DNA vaccine induced protection against lethal Yersinia pestis challenge.
Vaccine 2011;29(39):6802-9.
2011: Xiaofei E; Mary T Pickering; Michelle Debatis; Jonathan Castillo; Alexander Lagadinos; Shixia Wang; Shan Lu; Timothy F Kowalik
An E2F1-mediated DNA damage response contributes to the replication of human cytomegalovirus.
PLoS pathogens 2011;7(5):e1001342.
2011: Michael Vaine; Maria Duenas-Decamp; Paul Peters; Qin Liu; James Arthos; Shixia Wang; Paul R Clapham; Shan Lu
Two closely related Env antigens from the same patient elicited different spectra of neutralizing antibodies against heterologous HIV-1 isolates.
Journal of virology 2011;85(10):4927-36.
2011: Jun Li; Yaping Han; Ke Jin; Yufeng Wan; Shixia Wang; Bo Liu; Yuan Liu; Shan Lu; Zuhu Huang
Dynamic changes of cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells in patients with acute hepatitis B infection.
Virology journal 2011;8():199.
2011: Zheng Wang; Mingshun Zhang; Yan Wang; Yanmei Jiao; Lu Zhang; Lin Li; Zuhu Huang; Hao Wu; Jingyun Li; Shan Lu; Shixia Wang
A versatile vector for the production of pseudotyped viruses expressing gp120 antigens from different clades of primary HIV-1 isolates.
Journal of virological methods 2011;171(1):183-9.
2010: Shan Lu; Jill M Grimes Serrano; Shixia Wang
Polyvalent AIDS vaccines.
Current HIV research 2010;8(8):622-9.
2010: Ke Jin; Zuhu Huang; Shixia Wang; Shan Lu
Clostridium difficile infections in China.
Journal of biomedical research 2010;24(6):411-6.
2010: Meilong Shen; Shixia Wang; Guohong Ge; Yiping Xing; Xiuwen Ma; Zuhu Huang; Shan Lu
Profiles of B and T cell immune responses elicited by different forms of the hepatitis B virus surface antigen.
Vaccine 2010;28(45):7288-96.
2010: Shiyang Pan; Jian Xu; Yongqian Shu; Fang Wang; Wenying Xia; Qingqing Ding; Ting Xu; Chun Zhao; Meijuan Zhang; Peijun Huang; Shan Lu
Double recognition of oligonucleotide and protein in the detection of DNA methylation with surface plasmon resonance biosensors.
Biosensors & bioelectronics 2010;26(2):850-3.
2010: Yianmei Jiao; Tong Zhang; Shixia Wang; Qin Liu; Huifang Zhou; Shan Lu; Hao Wu
Profile of HIV-1 infected patients from an AIDS clinic in Beijing from 2007-2008.
Current HIV research 2010;8(7):515-20.
2010: Juan Xu; Yuan Qian; Shixia Wang; Jill M Grimes Serrano; Wei Li; Zuhu Huang; Shan Lu
EV71: an emerging infectious disease vaccine target in the Far East?
Vaccine 2010;28(20):3516-21.
2010: Michael Vaine; Shixia Wang; Anthony Hackett; James Arthos; Shan Lu
Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity.
Vaccine 2010;28(17):2999-3007.
2010: Shixia Wang; Innocent Mboudjeka; Jon Goguen; Shan Lu
Antigen engineering can play a critical role in the protective immunity elicited by Yersinia pestis DNA vaccines.
Vaccine 2010;28(8):2011-9.
2010: Ussama M Abdel-Motal; Shixia Wang; Amany Awad; Shan Lu; Kim Wigglesworth; Uri Galili
Increased immunogenicity of HIV-1 p24 and gp120 following immunization with gp120/p24 fusion protein vaccine expressing alpha-gal epitopes.
Vaccine 2010;28(7):1758-65.
2010: Michael Vaine; Shixia Wang; Qin Liu; James Arthos; David Montefiori; Paul Goepfert; M Juliana McElrath; Shan Lu
Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.
PloS one 2010;5(11):e13916.
2009: Shan Lu; Shixia Wang
Technical transformation of biodefense vaccines.
Vaccine 2009;27 Suppl 4():D8-D15.
2009: Shan Lu
Gene-based adjuvants: a new meaning.
Human gene therapy 2009;20(10):1101-2.
2009: Guifang Xu; Shixia Wang; Ling Zhuang; Anthony Hackett; Ling Gu; Lu Zhang; Chunhua Zhang; Hua Wang; Zuhu Huang; Shan Lu
Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
Vaccine 2009;27(29):3821-30.
2009: Shan Lu
Heterologous prime-boost vaccination.
Current opinion in immunology 2009;21(3):346-51.
2009: Qin Jiang; Cong Cao; Shan Lu; Rebecca Kivlin; Brittany Wallin; Wenming Chu; Zhigang Bi; Xinru Wang; Yinsheng Wan
MEK/ERK pathway mediates UVB-induced AQP1 downregulation and water permeability impairment in human retinal pigment epithelial cells.
International journal of molecular medicine 2009;23(6):771-7.
2009: Michael Vaine; Shan Lu; Shixia Wang
Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1).
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2009;23(3):137-53.
2008: Shan Lu
Immunogenicity of DNA vaccines in humans: it takes two to tango.
Human vaccines 2008;4(6):449-52.
2008: Yiping Xing; Zuhu Huang; Yan Lin; Jun Li; Te-Hui W Chou; Shan Lu; Shixia Wang
The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
Vaccine 2008;26(40):5145-52.
2008: Jeffrey S Kennedy; Mary Co; Sharone Green; Karen Longtine; Jaclyn Longtine; Melissa A O'Neill; Janice P Adams; Irene Bosch; Qiao Yu; Renita Johnson-Leva; Ranajit Pal; Shixia Wang; Shan Lu; Phillip Markham
The safety and tolerability of an HIV-1 DNA prime-protein boost vaccine (DP6-001) in healthy adult volunteers.
Vaccine 2008;26(35):4420-4.
2008: Michael Vaine; Shixia Wang; Emma T Crooks; Pengfei Jiang; David C Montefiori; James Binley; Shan Lu
Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccination.
Journal of virology 2008;82(15):7369-78.
2008: Shixia Wang; Jeffrey S Kennedy; Kim West; David C Montefiori; Scott Coley; John Lawrence; Siyuan Shen; Sharone Green; Alan L Rothman; Irene Bosch; James Arthos; Ranajit Pal; Phillip Markham; Shan Lu
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers.
Vaccine 2008;26(31):3947-57.
2008: Shixia Wang; Chris Parker; Jessica Taaffe; Alicia Solórzano; Adolfo García-Sastre; Shan Lu
Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.
Vaccine 2008;26(29-30):3626-33.
2008: Zuhu Huang; Arthur Chou; Jonathan Tanguay; Siyuan Shen; Innocent Mboudjeka; Te-Hui Chou; Shan Lu; Shixia Wang
Levels of N-linked glycosylation on the V1 loop of HIV-1 Env proteins and their relationship to the antigenicity of Env from primary viral isolates.
Current HIV research 2008;6(4):296-305.
2008: Shixia Wang; Chunghua Zhang; Lu Zhang; Jun Li; Zuhu Huang; Shan Lu
The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods.
Vaccine 2008;26(17):2100-10.
2008: Shixia Wang; Swati Joshi; Innocent Mboudjeka; Fangjun Liu; Tzufan Ling; Jon Goguen; Shan Lu
Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice.
Vaccine 2008;26(13):1664-74.
2008: Shan Lu; Shixia Wang; Jill M Grimes-Serrano
Current progress of DNA vaccine studies in humans.
Expert review of vaccines 2008;7(2):175-91.
2008: Shixia Wang; Jeffrey S Kennedy; Kim West; David C Montefiori; Scott Coley; John Lawrence; Siyuan Shen; Sharone Green; Alan L Rothman; Irene Bosch; James Arthos; Ranajit Pal; Phillip Markham; Shan Lu
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers.
Vaccine 2008;26(8):1098-110.
2008: Pavlo V Sakhatskyy; Shixia Wang; Chuanyou Zhang; Te-Hui W Chou; Michael Kishko; Shan Lu
Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.
Virology 2008;371(1):98-107.
2007: Kimberly Pouliot; Ning Pan; Shixia Wang; Shan Lu; Egil Lien; Jon Goguen
Evaluation of the role of LcrV-Toll-like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis.
Infection and immunity 2007;75(7):3571-80.
2007: Siyuan Shen; Shixia Wang; William J Britt; Shan Lu
DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates.
Vaccine 2007;25(17):3319-27.
2006: Shixia Wang; Jessica Taaffe; Christopher Parker; Alicia Solórzano; Hong Cao; Adolfo García-Sastre; Shan Lu
Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.
Journal of virology 2006;80(23):11628-37.
2006: Pavlo V Sakhatskyy; Shixia Wang; Te-Hui W Chou; Shan Lu
Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen.
Virology 2006;355(2):164-74.
2006: Shan Lu
Combination DNA plus protein HIV vaccines.
Springer seminars in immunopathology 2006;28(3):255-65.
2006: Subhabrata Biswas; Jan P M Langeveld; Donald Tipper; Shan Lu
Intracellular accumulation of a 46 kDa species of mouse prion protein as a result of loss of glycosylation in cultured mammalian cells.
Biochemical and biophysical research communications 2006;349(1):153-61.
2006: Ussama M Abdel-Motal; Shixia Wang; Shan Lu; Kim Wigglesworth; Uri Galili
Increased immunogenicity of human immunodeficiency virus gp120 engineered to express Galalpha1-3Galbeta1-4GlcNAc-R epitopes.
Journal of virology 2006;80(14):6943-51.
2006: Shixia Wang; Ranajit Pal; John Mascola; Te-Hui W Chou; Innocent Mboudjeka; Siyuan Shen; Qin Liu; Stephen Whitney; Timothy Keen; BC Nair; Vaniambadi S Kalyanaraman; Phillip Markham; Shan Lu
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E.
Virology 2006;350(1):34-47.
2006: Shixia Wang; Diego J Farfan-Arribas; Siyuan Shen; Te-Hui W Chou; Allison Hirsch; Feng He; Shan Lu
Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine.
Vaccine 2006;24(21):4531-40.
2006: Ranajit Pal; Vaniambadi S Kalyanaraman; BC Nair; Stephen Whitney; Timothy Keen; Lindsey Hocker; Lauren Hudacik; Nicolas Rose; Innocent Mboudjeka; Siyuan Shen; Te-Hui Wu-Chou; David Montefiori; John Mascola; Phillip Markham; Shan Lu
Immunization of rhesus macaques with a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype.
Virology 2006;348(2):341-53.
2006: Anthony D Cristillo; Shixia Wang; Michael S Caskey; Tami Unangst; Lindsey Hocker; Leilei He; Lauren Hudacik; Stephen Whitney; Timothy Keen; Te-Hui W Chou; Siyuan Shen; Swati Joshi; Vaniambadi S Kalyanaraman; Balachandran Nair; Phillip Markham; Shan Lu; Ranajit Pal
Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
Virology 2006;346(1):151-68.
2006: Ranajit Pal; Qiao Yu; Shixia Wang; Vaniambadi S Kalyanaraman; BC Nair; Lauren Hudacik; Stephen Whitney; Timothy Keen; Chia-Ling Hung; Lindsey Hocker; Jeffrey S Kennedy; Phillip Markham; Shan Lu
Definitive toxicology and biodistribution study of a polyvalent DNA prime/protein boost human immunodeficiency virus type 1 (HIV-1) vaccine in rabbits.
Vaccine 2006;24(8):1225-34.
2005: Ranajit Pal; Shixia Wang; Vaniambadi S Kalyanaraman; BC Nair; Stephen Whitney; Timothy Keen; Lindsey Hocker; Lauren Hudacik; Nicolas Rose; Anthony D Cristillo; Innocent Mboudjeka; Siyuan Shen; Te-Hui Wu-Chou; David Montefiori; John Mascola; Shan Lu; Phillip Markham
Polyvalent DNA prime and envelope protein boost HIV-1 vaccine elicits humoral and cellular responses and controls plasma viremia in rhesus macaques following rectal challenge with an R5 SHIV isolate.
Journal of medical primatology 2005;34(5-6):226-36.
2005: Yi-Ping Xing; Zu-hu Huang; Shi-Xia Wang; Jie Cai; Jun Li; Te-Hui W Chou; Shan Lu
Novel DNA vaccine based on hepatitis B virus core gene induces specific immune responses in Balb/c mice.
World journal of gastroenterology : WJG 2005;11(29):4583-6.
2005: Julia L Hurwitz; Karen S Slobod; Timothy D Lockey; Shixia Wang; Te-Hui W Chou; Shan Lu
Application of the polyvalent approach to HIV-1 vaccine development.
Current drug targets. Infectious disorders 2005;5(2):143-56.
2005: Shixia Wang; James Arthos; John M Lawrence; Donald Van Ryk; Innocent Mboudjeka; Siyuan Shen; Te-Hui W Chou; David C Montefiori; Shan Lu
Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1.
Journal of virology 2005;79(12):7933-7.
2005: Shixia Wang; Pavlo V Sakhatskyy; Te-Hui W Chou; Shan Lu
Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV).
Journal of immunological methods 2005;301(1-2):21-30.
2005: Te-Hui W Chou; Shixia Wang; Pavlo V Sakhatskyy; Innocent Mboudjeka; Innocent Mboudoudjeck; John M Lawrence; Song Huang; Scott Coley; Baoan Yang; Jiaming Li; Qingyu Zhu; Shan Lu
Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
Virology 2005;334(1):134-43.
2005: Shixia Wang; Te-Hui W Chou; Pavlo V Sakhatskyy; Song Huang; John M Lawrence; Hong Cao; Xiaoyun Huang; Shan Lu
Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system.
Journal of virology 2005;79(3):1906-10.
2004: Shixia Wang; Destin Heilman; Fangjun Liu; Theodore Giehl; Swati Joshi; Xiaoyun Huang; Te-Hui W Chou; Jon Goguen; Shan Lu
A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague.
Vaccine 2004;22(25-26):3348-57.
2004: Yi-Ping Xing; Zu-hu Huang; Shi-xia Wang; Jie Cai; Jun Li; Shan Lu
[Immunogenicity of new DNA vaccine encoding for hepatitis B virus core antigen].
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 2004;12(6):338-40.
2004: Fangjun Liu; Innocent Mboudjeka; Siyuan Shen; Te-Hui W Chou; Shixia Wang; Ted M Ross; Shan Lu
Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model.
Vaccine 2004;22(13-14):1764-72.
2004: Shixia Wang; Swati Joshi; Shan Lu
Delivery of DNA to skin by particle bombardment.
Methods in molecular biology (Clifton, N.J.) 2004;245():185-96.
2004: Te-Hui W Chou; Subhabrata Biswas; Shan Lu
Gene delivery using physical methods: an overview.
Methods in molecular biology (Clifton, N.J.) 2004;245():147-66.
2001: K Yang; Shixia Wang; K O Chang; Shan Lu; Linda J Saif; Harry B Greenberg; JP Brinker; John E Herrmann
Immune responses and protection obtained with rotavirus VP6 DNA vaccines given by intramuscular injection.
Vaccine 2001;19(23-24):3285-91.
2001: Zu-hu Huang; H Zhuang; Shan Lu; R H Guo; G M Xu; Jie Cai; W F Zhu
Humoral and cellular immunogenecity of DNA vaccine based on hepatitis B core gene in rhesus monkeys.
World journal of gastroenterology : WJG 2001;7(1):102-6.
2000: Shan Lu; S Manning; J Arthos
Antigen engineering in DNA immunization.
Methods in molecular medicine 2000;29():355-74.
1999: Z Huang; Shan Lu; Ning Liu
[Humoral and cellular immunogenecity of genetic vaccine on core gene of hepatitis B virus in mice].
Zhonghua yi xue za zhi 1999;79(6):456-9.
1999: Z Huang; Shan Lu; Ning Liu
[Specific immune responses in H-2d mice after DNA immunization of HBV core gene].
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 1999;7(2):107-9.
1998: JF Richmond; Shan Lu; JC Santoro; J Weng; S L Hu; David C Montefiori; Harriet L Robinson
Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting.
Journal of virology 1998;72(11):9092-100.
1998: Shan Lu; Richard Wyatt; JF Richmond; Farah Mustafa; Shixia Wang; J Weng; David C Montefiori; Joseph Sodroski; Harriet L Robinson
Immunogenicity of DNA vaccines expressing human immunodeficiency virus type 1 envelope glycoprotein with and without deletions in the V1/2 and V3 regions.
AIDS research and human retroviruses 1998;14(2):151-5.
1998: Shan Lu
Developing DNA vaccines against immunodeficiency viruses.
Current topics in microbiology and immunology 1998;226():161-73.
1997: Shan Lu; Kelledy Manson; Michael S Wyand; Harriet L Robinson
SIV DNA vaccine trial in macaques: post-challenge necropsy in vaccine and control groups.
Vaccine 1997;15(8):920-3.
1997: SC Chen; EF Fynan; Harriet L Robinson; Shan Lu; Harry B Greenberg; JC Santoro; John E Herrmann
Protective immunity induced by rotavirus DNA vaccines.
Vaccine 1997;15(8):899-902.
1997: JF Richmond; Farah Mustafa; Shan Lu; JC Santoro; J Weng; M O'Connell; Eva Maria Fenyö; J L Hurwitz; David C Montefiori; Harriet L Robinson
Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting.
Virology 1997;230(2):265-74.
1997: Farah Mustafa; JF Richmond; R Fernandez-Larsson; Shan Lu; R Fredriksson; Eva Maria Fenyö; M O'Connell; E Johnson; J Weng; JC Santoro; Harriet L Robinson
HIV-1 Env glycoproteins from two series of primary isolates: replication phenotype and immunogenicity.
Virology 1997;229(1):269-78.
1996: Shan Lu; J Arthos; D C Montefiori; Y Yasutomi; Kelledy Manson; Farah Mustafa; E Johnson; JC Santoro; J Wissink; J I Mullins; Joel R Haynes; Norman L Letvin; Michael S Wyand; Harriet L Robinson
Simian immunodeficiency virus DNA vaccine trial in macaques.
Journal of virology 1996;70(6):3978-91.
1996: Harriet L Robinson; Shan Lu; DM Feltquate; C T Torres; J Richmond; C M Boyle; M J Morin; JC Santoro; Robert G Webster; D Montefiori; Y Yasutomi; Norman L Letvin; Kelledy Manson; Michael S Wyand; Joel R Haynes
DNA vaccines.
AIDS research and human retroviruses 1996;12(5):455-7.
1996: Y Yasutomi; Harriet L Robinson; Shan Lu; Farah Mustafa; C Lekutis; J Arthos; J I Mullins; G Voss; Kelledy Manson; Michael S Wyand; Norman L Letvin
Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys.
Journal of virology 1996;70(1):678-81.
1995: J B Livingston; Shan Lu; Harriet L Robinson; D J Anderson
The induction of mucosal immunity in the female genital tract using gene-gun technology. Part 1: Antigen expression.
Annals of the New York Academy of Sciences 1995;772():265-7.
1995: Harriet L Robinson; Shan Lu; Farah Mustafa; E Johnson; JC Santoro; J Arthos; J Winsink; J I Mullins; D Montefiori; Y Yasutomi
Simian immunodeficiency virus DNA vaccine trial in macaques.
Annals of the New York Academy of Sciences 1995;772():209-11.
1995: Shan Lu; JC Santoro; Deborah H Fuller; Joel R Haynes; Harriet L Robinson
Use of DNAs expressing HIV-1 Env and noninfectious HIV-1 particles to raise antibody responses in mice.
Virology 1995;209(1):147-54.
1992: Shan Lu; S D Putney; Harriet L Robinson
Human immunodeficiency virus type 1 entry into T cells: more-rapid escape from an anti-V3 loop than from an antireceptor antibody.
Journal of virology 1992;66(4):2547-50.
1992: R Fernandez-Larsson; K K Srivastava; Shan Lu; Harriet L Robinson
Replication of patient isolates of human immunodeficiency virus type 1 in T cells: a spectrum of rates and efficiencies of entry.
Proceedings of the National Academy of Sciences of the United States of America 1992;89(6):2223-6.
1992: Shan Lu; Victor E Reyes; C M Bositis; T G Goldschmidt; V Lam; R R Torgerson; T Ciardelli; L Hardy; R A Lew; R E Humphreys
Biophysical mechanism of the scavenger site near T cell-presented epitopes.
Vaccine 1992;10(1):3-7.
1991: Shan Lu; Victor E Reyes; R R Torgerson; R A Lew; R E Humphreys
Common principles in protein folding and antigen presentation.
Trends in biotechnology 1991;9(7):238-42.
1991: Shan Lu; T Ciardelli; Victor E Reyes; R E Humphreys
Number and placement of hydrophobic residues in a longitudinal strip governs helix formation of peptides in the presence of lipid vesicles.
The Journal of biological chemistry 1991;266(16):10054-7.
1991: Victor E Reyes; Shan Lu; R E Humphreys
Cathepsin B cleavage of Ii from class II MHC alpha- and beta-chains.
Journal of immunology (Baltimore, Md. : 1950) 1991;146(11):3877-80.
1990: Shan Lu; Victor E Reyes; R A Lew; J Anderson; J Mole; R E Humphreys; T Ciardelli
Role of recurrent hydrophobic residues in catalysis of helix formation by T cell-presented peptides in the presence of lipid vesicles.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(3):899-904.
1987: William L. Elliott; Shan Lu; Q Nguyen; P S Reisert; T Sairenji; C H Sorli; C J Stille; L J Thomas; R E Humphreys
Hyperexpressed hairy leukemic cell Ii might bind to the antigen-presenting site of class II MHC molecules.
Leukemia 1987;1(4):395-6.